MicroRNA and Helicobacter pylori-associated gastric carcinoma

doi:10.3760/cma.j.issn.1673-422X.2017.11.016

Abstract

Abstract: Helicobacter pylori infection can cause a series of microRNAs (miRNAs) disorders. These abnormal expressions of miRNAs can participate in the genesis and development of Helicobacter pyloriassociated gastric carcinoma through regulating cell proliferation, differentiation and apoptosis. Identifying the targets and regulatory pathways of various miRNAs in the development of Helicobacter pyloriassociated gastric cancer will provide a new direction for early diagnosis, prognosis and individualized treatment of gastric cancer.

Key words: MicroRNAs, Gastric neoplasms, Helicobacter pylori

李春霞，王学红. MicroRNA and Helicobacter pylori-associated gastric carcinoma[J]. Journal of International Oncology, 2017, 44(11): 866-868.

References

［1］ Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012［J］. Int J Cancer, 2015, 136(5): E359-386. DOI: 10.1002/ijc.29210. ［2］ Liu J, Liu H, Zhang T, et al. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer［J］. Sci Rep, 2014, 4: 4143. DOI: 10.1038/srep04143. ［3］ Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells［J］. Nature, 2012, 489(7414): 101-108. DOI: 10.1038/nature11233. ［4］ Guttman M, Rinn JL. Modular regulatory principles of large noncoding RNAs［J］. Nature, 2012, 482(7385): 339-346. DOI: 10.1038/nature 10887. ［5］ Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA［J］. Cell, 2013, 153(3): 516-519. DOI: 10.1016/j.cell.2013.04.003. ［6］ Ha M, Kim VN. Regulation of microRNA biogenesis［J］. Nat Rev Mol Cell Biol, 2014, 15(8): 509-524. DOI: 10.1038/nrm3838. ［7］ Liang J, Liu X, Xue H, et al. MicroRNA103a inhibits gastric cancer cell proliferation, migration and invasion by targeting cMyb［J］. Cell Prolif, 2015, 48(1): 78-85. DOI: 10.1111/cpr.12159. ［8］ Zeng Y, Fu M, Wu GW, et al. Upregulation of microRNA370 promotes cell apoptosis and inhibits proliferation by targeting PTEN in human gastric cancer［J］. Inte J Oncol, 2016, 49(4): 15891599. DOI: 10.3892/ijo.2016.3642. ［9］ Lin M, Shi C, Lin X, et al. sMicroRNA1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells［J］. Gene, 2016, 582(2): 137-142. DOI: 10.1016/j.gene.2016.02.001. ［10］ Zhang Y, Li CF, Ma LJ, et al. MicroRNA224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer［J］. Int J Oncol, 2016, 49(3): 1068-1080. DOI: 10.3892/ijo.2016.3581. ［11］ Ma L, Chen Y, Zhang B, et al. Increased microRNA223 in Helicobacter pyloriassociated gastric cancer contributed to cancer cell proliferation and migration［J］. Biosci Biotechnol Biochem, 2014, 78(4): 602608. DOI: 10.1080/09168451.2014.895661. ［12］ Li J, Guo Y, Liang X, et al. MicroRNA223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4［J］. J Cancer Res Clin Oncol, 2012, 138(5): 763-774. DOI: 10.1007/s004320121154x. ［13］ Eto K, Iwatsuki M, Watanabe M, et al. The sensitivity of gastric cancer to trastuzumab is regulated by the miR223/FBXW7 pathway［J］. Int J Cancer, 2015, 136(7): 1537-1545. DOI: 10.1002/ijc.29168. ［14］ Liu W, Song N, Yao H, et al. miR221 and miR222 simultaneously target RECK and regulate growth and invasion of gastric cancer cells［J］. Med Sci Monit, 2015, 21: 2718-2725. DOI: 10.12659/MSM.894324. ［15］ Miao L, Liu K, Xie M, et al. miR375 inhibits Helicobacter pyloriinduced gastric carcinogenesis by blocking JAK2STAT3 signaling［J］. Cancer Immunol Immunother, 2014, 63(7): 699-711. DOI: 10.1007/s00262-014-1550-y. ［16］ Zhou X, Xia Y, Su J, et al. Downregulation of miR141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4［J］. Cell Physiol Biochem, 2014, 33(4): 1003-1012. DOI: 10.1159/000358671. ［17］ Du Y, Wang L, Wu H, et al. MicroRNA141 inhibits migration of gastric cancer by targeting zinc finger Eboxbinding homeobox 2［J］. Mol Med Rep, 2015, 12(3): 3416-3422. DOI: 10.3892/mmr.2015.3789. ［18］ Zhou X, Su J, Zhu L, et al. Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by downregulating miR141 expression［J］. Helicobacter, 2014, 19(3): 174-181. DOI: 10.1111/hel.12120. ［19］ Geng Y, Lu X, Wu X, et al. MicroRNA27b suppresses Helicobacter pyloriinduced gastric tumorigenesis through negatively regulating Frizzled7［J］. Oncol Rep, 2016, 35(4): 2441-2450. DOI: 10.3892/or.2016.4572. ［20］ Feng Q, Wu X, Li F, et al. miR27b inhibits gastric cancer metastasis by targeting NR2F2［J］. Protein Cell, 2017, 8(2): 114-122. DOI: 10.1007/s13238-016-0340-z. ［21］ Zhou X, Xia Y, Li L, et al. MiR101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2［J］. Cancer Biol Ther, 2015, 16(1): 160-169. DOI: 10.4161/15384047.2014.987523. ［22］ He XP, Shao Y, Li XL, et al. Downregulation of miR101 in gastric cancer correlates with cyclooxygenase2 overexpression and tumor growth［J］. FEBS J, 2012, 279(22): 4201-4212. DOI: 10.1111/febs.12013. ［23］ Bao J, Xu Y, Wang Q, et al. miR101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2［J］. Biomed Pharmacother, 2017, 92: 1030-1037. DOI: 10.1016/j.biopha.2017.06.011.

[1]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[2]	Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190.
[3]	Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu. Level of serum FABP1 and its relationship with Helicobacter pylori infection in patients with gastric cancer [J]. Journal of International Oncology, 2023, 50(6): 336-341.
[4]	Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells [J]. Journal of International Oncology, 2023, 50(5): 257-262.
[5]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[6]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[7]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing. MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2 [J]. Journal of International Oncology, 2022, 49(4): 193-198.
[8]	Jin Jiahui, Chen Cunhai, Ma Xuezhen. Effects of radiation-associated miRNA in radiotherapy for breast cancer [J]. Journal of International Oncology, 2022, 49(12): 735-738.
[9]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei. Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer [J]. Journal of International Oncology, 2022, 49(11): 681-686.
[10]	Cai Jiahui, Rong Guanghong. Mechanism and clinical significance of YAP in the progression of gastric cancer [J]. Journal of International Oncology, 2022, 49(11): 687-691.
[11]	Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin. Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis [J]. Journal of International Oncology, 2022, 49(1): 45-50.
[12]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang. Research progress on lncRNAs as members of ceRNA network in melanoma [J]. Journal of International Oncology, 2022, 49(1): 61-64.
[13]	Hu Guangyue, Yin Hong, Zhang Hui, Luo Hong. Efficacy predictors of immune checkpoint inhibitors in the treatment of metastatic gastric cancer [J]. Journal of International Oncology, 2021, 48(8): 498-501.
[14]	Liu Pei, Pu Jiaze, Huang Wen, Wang Fei. Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis [J]. Journal of International Oncology, 2021, 48(7): 409-414.
[15]	Wang Yang, Liu Qian, Long Hui, Wu Qingming. Research status of fecal detection for colorectal cancer markers [J]. Journal of International Oncology, 2021, 48(7): 441-444.